Market Research

North America Microbiome Diagnostics Market Size, Share & Trends Analysis Report By Application, By Product (Reagents & Kits and Instruments), By Sample (Fecal, Saliva, Skin, and Others), By Technology, By End User, By Country and Growth Forecast, 2023 -

Best Price Guarantee Length Publisher Published Date SKU
from $1,500 123 Pages Knowledge Based Value (KBV) Research March, 2024 KBV18686806
Best Price Guarantee
Price from $1,500
Length 123 Pages
Publisher Knowledge Based Value (KBV) Research
Published Date March, 2024
SKU KBV18686806

North America Microbiome Diagnostics Market Size, Share & Trends Analysis Report By Application, By Product (Reagents & Kits and Instruments), By Sample (Fecal, Saliva, Skin, and Others), By Technology, By End User, By Country and Growth Forecast, 2023 - 2030


The North America Microbiome Diagnostics Market would witness market growth of 16.9% CAGR during the forecast period (2023-2030).

The US market dominated the North America Microbiome Diagnostics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $157,641.6 Thousands by 2030. The Canada market is exhibiting a CAGR of 19.5% during (2023 - 2030). Additionally, The Mexico market would experience a CAGR of 19.1% during (2023 - 2030).

It is increasingly integrated into clinical practice, particularly in gastroenterology, oncology, immunology, dermatology, and women’s health. Clinicians utilize microbiome diagnostics to aid in disease diagnosis, risk assessment, treatment selection, and monitoring of therapeutic responses. For example, in gastroenterology, it helps identify microbial biomarkers associated with inflammatory bowel diseases (IBD), irritable bowel syndrome (IBS), and colorectal cancer, guiding personalized treatment strategies and dietary interventions. In dermatology, it is used to study the skin microbiome and its role in dermatological conditions such as acne, eczema, and psoriasis, informing skincare interventions and therapeutic approaches. The adoption of microbiome diagnostics in clinical settings is driven by the need for more precise and personalized healthcare solutions tailored to individual patient characteristics and microbial profiles.

Additionally, it is widely utilized in research laboratories to investigate microbiome-host interactions, disease mechanisms, and therapeutic targets. Academic institutions, biotechnology companies, and pharmaceutical firms invest in microbiome research initiatives, leveraging microbiome diagnostics to drive innovation in drug discovery, biomarker identification, and therapeutic development. Researchers utilize microbiome diagnostics to study microbial communities’ composition, diversity, and function in various disease states, environmental contexts, and experimental models. It enables researchers to unravel the complex relationships between microbial communities and host physiology, paving the way for discoveries and breakthroughs in microbiome research.

Mexico’s pharmaceutical sector’s growth can provide financial resources and infrastructure support for clinical trials and research initiatives focused on microbiome-based interventions. The pharmaceutical sector in Mexico is divided into patented medicines, which represent 51 percent of the market by value, generics, which represent 35 percent, and over-the-counter products, which represent the remaining 14 percent. As the pharmaceutical sector expands in Mexico, there may be a growing interest in microbiome-based therapeutics for various diseases and conditions. Hence, the increasing investments in the healthcare sector and the rising pharmaceutical industry in the region are propelling the market’s growth.

Based on Application, the market is segmented into Disease Diagnostics (Gastrointestinal Disorders, Metabolic Diseases and Others) and Research Application. Based on Product, the market is segmented into Reagents & Kits and Instruments. Based on Sample, the market is segmented into Fecal, Saliva, Skin, and Others. Based on Technology, the market is segmented into 16S rRNA Sequencing, Shot Gun Metagenomics, Metatranscriptomics and Others. Based on End User, the market is segmented into Hospitals, Academic & Research Institutes, and Biotechnology & Pharmaceutical Companies. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled
  • Illumina, Inc.
  • Becton, Dickinson and Company
  • Genetic Analysis AS
  • Microba Life Sciences Limited
  • BioMe Oxford Ltd
  • Viome Life Sciences, Inc.
  • GoodGut S.L.U. (HIPRA, S.A.)
  • Sun Genomics
  • Origin Sciences Limited
  • Decode Age
North America Microbiome Diagnostics Market Report Segmentation

By Application
  • Disease Diagnostics
  • Gastrointestinal Disorders
  • Metabolic Diseases
  • Others
  • Research Application
By Product
  • Reagents & Kits
  • Instruments
By Sample
  • Fecal
  • Saliva
  • Skin
  • Others
By Technology
  • 16S rRNA Sequencing
  • Shot Gun Metagenomics
  • Metatranscriptomics
  • Others
By End User
  • Hospitals
  • Academic & Research Institutes
  • Biotechnology & Pharmaceutical Companies
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Microbiome Diagnostics Market, by Application
1.4.2 North America Microbiome Diagnostics Market, by Product
1.4.3 North America Microbiome Diagnostics Market, by Sample
1.4.4 North America Microbiome Diagnostics Market, by Technology
1.4.5 North America Microbiome Diagnostics Market, by End User
1.4.6 North America Microbiome Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Strategies Deployed in Microbiome Diagnostics Market
Chapter 5. North America Microbiome Diagnostics Market by Application
5.1 North America Disease Diagnostics Market by Region
5.2 North America Microbiome Diagnostics Market by Disease Diagnostics Type
5.2.1 North America Gastrointestinal Disorders Market by Country
5.2.2 North America Metabolic Diseases Market by Country
5.2.3 North America Others Market by Country
5.3 North America Research Application Market by Region
Chapter 6. North America Microbiome Diagnostics Market by Product
6.1 North America Reagents & Kits Market by Country
6.2 North America Instruments Market by Country
Chapter 7. North America Microbiome Diagnostics Market by Sample
7.1 North America Fecal Market by Country
7.2 North America Saliva Market by Country
7.3 North America Skin Market by Country
7.4 North America Others Market by Country
Chapter 8. North America Microbiome Diagnostics Market by Technology
8.1 North America 16S rRNA Sequencing Market by Country
8.2 North America Shot Gun Metagenomics Market by Country
8.3 North America Metatranscriptomics Market by Country
8.4 North America Others Market by Country
Chapter 9. North America Microbiome Diagnostics Market by End User
9.1 North America Hospitals Market by Country
9.2 North America Academic & Research Institutes Market by Country
9.3 North America Biotechnology & Pharmaceutical Companies Market by Country
Chapter 10. North America Microbiome Diagnostics Market by Country
10.1 US Microbiome Diagnostics Market
10.1.1 US Microbiome Diagnostics Market by Application
10.1.1.1 US Microbiome Diagnostics Market by Disease Diagnostics Type
10.1.2 US Microbiome Diagnostics Market by Product
10.1.3 US Microbiome Diagnostics Market by Sample
10.1.4 US Microbiome Diagnostics Market by Technology
10.1.5 US Microbiome Diagnostics Market by End User
10.2 Canada Microbiome Diagnostics Market
10.2.1 Canada Microbiome Diagnostics Market by Application
10.2.1.1 Canada Microbiome Diagnostics Market by Disease Diagnostics Type
10.2.2 Canada Microbiome Diagnostics Market by Product
10.2.3 Canada Microbiome Diagnostics Market by Sample
10.2.4 Canada Microbiome Diagnostics Market by Technology
10.2.5 Canada Microbiome Diagnostics Market by End User
10.3 Mexico Microbiome Diagnostics Market
10.3.1 Mexico Microbiome Diagnostics Market by Application
10.3.1.1 Mexico Microbiome Diagnostics Market by Disease Diagnostics Type
10.3.2 Mexico Microbiome Diagnostics Market by Product
10.3.3 Mexico Microbiome Diagnostics Market by Sample
10.3.4 Mexico Microbiome Diagnostics Market by Technology
10.3.5 Mexico Microbiome Diagnostics Market by End User
10.4 Rest of North America Microbiome Diagnostics Market
10.4.1 Rest of North America Microbiome Diagnostics Market by Application
10.4.1.1 Rest of North America Microbiome Diagnostics Market by Disease Diagnostics Type
10.4.2 Rest of North America Microbiome Diagnostics Market by Product
10.4.3 Rest of North America Microbiome Diagnostics Market by Sample
10.4.4 Rest of North America Microbiome Diagnostics Market by Technology
10.4.5 Rest of North America Microbiome Diagnostics Market by End User
Chapter 11. Company Profiles
11.1 Illumina, Inc.
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Regional Analysis
11.1.4 Research & Development Expense
11.1.5 Recent strategies and developments:
11.1.5.1 Partnerships, Collaborations, and Agreements:
11.1.6 SWOT Analysis
11.2 Becton, Dickinson, and Company
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Segmental and Regional Analysis
11.2.4 Research & Development Expense
11.2.5 Recent strategies and developments:
11.2.5.1 Product Launches and Product Expansions:
11.2.5.2 Trails and Approvals:
11.2.6 SWOT Analysis
11.3 Genetic Analysis AS
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Regional Analysis
11.3.4 Recent strategies and developments:
11.3.4.1 Partnerships, Collaborations, and Agreements:
11.4 Microba Life Sciences Limited
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Regional Analysis
11.4.4 Research & Development Expenses
11.4.5 Recent strategies and developments:
11.4.5.1 Partnerships, Collaborations, and Agreements:
11.4.5.2 Product Launches and Product Expansions:
11.5 BioMe Oxford Ltd
11.5.1 Company Overview
11.5.2 Recent strategies and developments:
11.5.2.1 Partnerships, Collaborations, and Agreements:
11.6 Viome Life Sciences, Inc.
11.6.1 Company Overview
11.6.2 Recent strategies and developments:
11.6.2.1 Product Launches and Product Expansions:
11.6.2.2 Acquisition and Mergers:
11.7 GoodGut S.L.U. (HIPRA, S.A.)
11.7.1 Company Overview
11.8 Sun Genomics
11.8.1 Company Overview
11.9 Origin Sciences Limited
11.9.1 Company Overview
11.10. Decode Age
11.10.1 Company Overview

$1,500
$1,800
$2,520

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings